Filing Details
- Accession Number:
- 0001161697-15-000446
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-23 18:17:17
- Reporting Period:
- 2015-10-23
- Filing Date:
- 2015-10-23
- Accepted Time:
- 2015-10-23 18:17:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1378683 | Douglas M Winship | 355 Alhambra Circle, Suite 1250 Coral Gables FL 33134 | Vp, Regulatory Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Disposition | 2015-10-23 | 22,800 | $3.34 | 74,131 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares were sold principally for the purpose of funding the exercise of stock options that will expire in November 2015. The exercise of the stock options using the proceeds of this sale will be reported in a separate Form 4.